Home > Insider Trading > Filing (0000899243-21-021981)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1787400	Nkarta Inc.	NKTX	Pharmaceutical Preparations (2834)	474515206

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1853197	Ralph Brandenberger	C/O Nkarta, Inc. 6000 Shoreline Court, Suite 102 South San Francisco CA 94080	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-06-02	340	$0.41	340	No	4	M	Direct
Common Stock	Acquisiton	2021-06-02	405	$4.77	745	No	4	M	Direct
Common Stock	Acquisiton	2021-06-02	1,358	$3.89	2,103	No	4	M	Direct
Common Stock	Acquisiton	2021-06-02	2,037	$3.89	4,140	No	4	M	Direct
Common Stock	Disposition	2021-06-02	4,140	$24.50	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2021-06-02	340	$0.00	340	$0.41
Common Stock	Stock Option (right to buy)	Disposition	2021-06-02	405	$0.00	405	$4.77
Common Stock	Stock Option (right to buy)	Disposition	2021-06-02	1,358	$0.00	1,358	$3.89
Common Stock	Stock Option (right to buy)	Disposition	2021-06-02	2,037	$0.00	2,037	$3.89

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
8,387	2028-07-18	No	4	M	Direct
10,000	2029-05-10	No	4	M	Direct
33,500	2029-09-05	No	4	M	Direct
50,250	2029-09-05	No	4	M	Direct

Footnotes

The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.
The option is vested and exercisable as to 6,498 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on April 2, 2022.
The option is vested and exercisable as to 5,721 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on December 6, 2022.
The option is vested and exercisable as to 5,583 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on July 1, 2024.
The option is vested and exercisable as to 18,561 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on September 5, 2023.